Share

    


Home / Search Results

Search Results

You searched for:

    Displaying results 1 - 20 of 35
  • 1
  • 2
  • »
The shortage of chemotherapy drugs is placing a considerable burden on cancer care providers. To end this, ACCC is working its members, as well as other provider and patient advocacy organizations, to identify potential policy solutions.
In the face of an unprecedented drug shortage, Hematology/Oncology Pharmacy Association (HOPA) partnered with the Association of Community Cancer Centers (ACCC) and Association of VA Hematology/Oncology (AVAHO) to lead a virtual round table aimed at developing practical strategies healthcare organizations around the country can adopt.
The substantial strain placed on health care workers and organizations by unnecessary ED visits prompted Orlando Health Cancer Institute to develop their express symptom management program in July 2021. The program was designed to effectively triage and treat cancer related symptoms in the outpatient setting.
Ochsner Health, Ochsner Cancer Institute developed a program to remotely monitor patients on intravenous or oral anti-cancer treatment.
March is Multiple Myeloma Awareness Month. Learn more about the work ACCC is doing to support oncology professionals in treating patients with this disease.
As the director of Oncology Supportive Services at M Health Fairview, Jeff Kendall Psy D, LP has spearheaded the implementation of an electronic patient-reported outcomes program that will give healthcare providers an unprecedented insight on the symptoms patients may be experiencing.
The increase in incidents of cardiotoxicity due to a number of cancer treatment modalities necessitates the need for cardio-oncology.
ACCCBuzz spoke with Dr. Dan Vogl to learn more about the treatment options available to patients with multiple myeloma, including the benefits of adding anti-CD38 monoclonal antibodies in either first- or second-line treatment.
The HealthPartners Frauenshuh Cancer Center has safely incorporated cannabis in the treatment of patients with cancer.
ACCC has launched Transforming Complex to Clear—a precision medicine campaign that has developed a range of tools and resources to help bring clarity to complex patient care decisions. Designed for multidisciplinary cancer teams, learn more about how these resources can enable clinicians to make educated and confident decisions.
Learn the 10 feasible and impactful “how-tos” Summit participants identified within three domains—care coordination and communication, clinical trials, and acknowledging and mitigating implicit bias.
Regardless of the reason, the ability to bill for discontinued services will depend on why the service had to be stopped and how it was addressed.
An expert ACCC Steering Committee shares 32 informed treatment and care delivery recommendations for the ideal care of patients with non-small cell lung cancer.
In addition to the global pandemic, ongoing lawsuits from referenced biologics' manufacturers suing biosimilar manufacturers are having a negative impact on the development and approval of new biosimilars.
This ACCC education program shares key highlights from a national survey of thoracic surgeons, radiation oncologists, and medical oncologists on the barriers that exist in the ideal management of patients with NSCLC.
Providers and staff at the University of Arizona Cancer Center, along with published literature, report that patients want to receive their therapies in the outpatient setting when possible
Dr. Vijay Rao and Dr. Eric Stephen Rubenstein returned from a Global Cardio-Oncology Society meeting g with the realization that they could do much more to protect patients with cancer from potential cardiac toxicity of chemotherapy. The two shared one goal: to prevent the cancer survivor of today from becoming the heart failure patient of tomorrow.
This blog is the eighth of an eight-part ACCCBuzz series highlighting the achievements of the 2020 ACCC Innovator Award Winners. You can learn more about the innovations being recognized this year and the people who pioneered them by joining us at the upcoming ACCC 37th [Virtual] National Oncology Conference, September 14-18. Largely due to the necessity of being able to respond quickly to potential …
In response to the increasing complexity of oncolytic agents, the associated economic burden on the patient and health system, and the intricacies associated with alternative payment models (APMs), I suggest the need for widespread establishment of chemotherapy stewardship services.
Learn how Advocate-Aurora Lutheran General Hospital, Ill., modified an unused space in its inpatient oncology unit to create an outpatient oncology symptom management treatment area. The program now sees cancer patients outside of traditional office hours, thereby reducing ED visits and hospitalizations.
    Displaying results 1 - 20 of 35
  • 1
  • 2
  • »